These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38602692)

  • 1. Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial.
    de Almeida JR; Martino R; Hosni A; Goldstein DP; Bratman SV; Chepeha DB; Waldron JN; Weinreb I; Perez-Ordonez B; Yu E; Metser U; Hansen AR; Xu W; Su SJ; Kim J
    JAMA Otolaryngol Head Neck Surg; 2024 Jun; 150(6):463-471. PubMed ID: 38602692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Finding/identifying primaries with neck disease (FIND) clinical trial protocol: a study integrating transoral robotic surgery, histopathological localisation and tailored deintensification of radiotherapy for unknown primary and small oropharyngeal head and neck squamous cell carcinoma.
    de Almeida JR; Noel CW; Veigas M; Martino R; Chepeha DB; Bratman SV; Goldstein DP; Hansen AR; Yu E; Metser U; Weinreb I; Perez-Ordonez B; Xu W; Kim J
    BMJ Open; 2019 Dec; 9(12):e035431. PubMed ID: 31892671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharyngeal-sparing radiation for head and neck carcinoma of unknown primary following TORS assisted work-up.
    Grewal AS; Rajasekaran K; Cannady SB; Chalian AA; Ghiam AF; Lin A; LiVolsi V; Lukens JN; Mitra N; Montone KT; Newman JG; O'Malley BW; Rassekh CH; Weinstein GS; Swisher-McClure S
    Laryngoscope; 2020 Mar; 130(3):691-697. PubMed ID: 31411747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy Characteristics and Outcomes for Head and Neck Carcinoma of Unknown Primary vs T1 Base-of-Tongue Carcinoma.
    Hosni A; Dixon PR; Rishi A; Au M; Xu W; Song Y; Chepeha DB; Goldstein DP; Huang SH; Kim J; O'Sullivan B; Waldron J; Bratman SV; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1208-1215. PubMed ID: 27812692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-operative therapy following transoral robotic surgery for unknown primary cancers of the head and neck.
    Patel SA; Parvathaneni A; Parvathaneni U; Houlton JJ; Karni RJ; Liao JJ; Futran ND; Méndez E
    Oral Oncol; 2017 Sep; 72():150-156. PubMed ID: 28797451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial.
    Palma DA; Prisman E; Berthelet E; Tran E; Hamilton S; Wu J; Eskander A; Higgins K; Karam I; Poon I; Husain Z; Enepekides D; Hier M; Sultanem K; Richardson K; Mlynarek A; Johnson-Obaseki S; Odell M; Bayley A; Dowthwaite S; Jackson JE; Dzienis M; O'Neil J; Chandarana S; Banerjee R; Hart R; Chung J; Tenenholtz T; Krishnan S; Le H; Yoo J; Mendez A; Winquist E; Kuruvilla S; Stewart P; Warner A; Mitchell S; Chen J; Parker C; Wehrli B; Kwan K; Theurer J; Sathya J; Hammond JA; Read N; Venkatesan V; MacNeil SD; Fung K; Nichols AC
    JAMA Oncol; 2022 Jun; 8(6):1-7. PubMed ID: 35482348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
    Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
    Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Swallowing After Primary TORS and Unilateral or Bilateral Radiation for Low- to Intermediate-Risk Tonsil Cancer.
    Barbon CEA; Yao CMK; Peterson CB; Moreno AC; Goepfert RP; Johnson FM; Chronowski GM; Fuller CD; Gross ND; Hutcheson KA
    Otolaryngol Head Neck Surg; 2022 Sep; 167(3):484-493. PubMed ID: 34784256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx.
    Swisher-McClure S; Lukens JN; Aggarwal C; Ahn P; Basu D; Bauml JM; Brody R; Chalian A; Cohen RB; Fotouhi-Ghiam A; Geiger G; Gershowitz J; Livolsi V; Mitra N; Montone K; Newman J; Ojerholm E; O'Malley B; Rajasekaran K; Tan E; Weinstein G; Lin A
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):725-732. PubMed ID: 31785337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.
    Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
    J Clin Oncol; 2022 Mar; 40(8):866-875. PubMed ID: 34995124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transoral robotic surgery for management of cervical unknown primary squamous cell carcinoma: Updates on efficacy, surgical technique and margin status.
    Geltzeiler M; Doerfler S; Turner M; Albergotti WG; Kubik M; Kim S; Ferris R; Duvvuri U
    Oral Oncol; 2017 Mar; 66():9-13. PubMed ID: 28249654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
    Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
    Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transoral Robotic Surgery-Assisted Endoscopy With Primary Site Detection and Treatment in Occult Mucosal Primaries.
    Hatten KM; O'Malley BW; Bur AM; Patel MR; Rassekh CH; Newman JG; Cannady SB; Chalian AA; Hodnett BL; Lin A; Lukens JN; Cohen RB; Bauml JM; Montone KT; Livolsi VA; Weinstein GS
    JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):267-273. PubMed ID: 27930761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial.
    Nichols AC; Yoo J; Hammond JA; Fung K; Winquist E; Read N; Venkatesan V; MacNeil SD; Ernst DS; Kuruvilla S; Chen J; Corsten M; Odell M; Eapen L; Theurer J; Doyle PC; Wehrli B; Kwan K; Palma DA
    BMC Cancer; 2013 Mar; 13():133. PubMed ID: 23514246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma-A large observational single-centre series from the United Kingdom.
    O'Hara J; Warner L; Fox H; Hamilton D; Meikle D; Counter P; Robson A; Goranova R; Iqbal S; Kelly C; Robinson M; Paleri V
    Clin Otolaryngol; 2021 Sep; 46(5):1005-1012. PubMed ID: 33754476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer.
    Hutcheson KA; Warneke CL; Yao CMKL; Zaveri J; Elgohari BE; Goepfert R; Hessel AC; Kupferman ME; Lai SY; Fuller CD; Gunn GB; Garden AS; Johnson F; Ferrarotto R; Lewin JS; Gross ND;
    JAMA Otolaryngol Head Neck Surg; 2019 Nov; 145(11):1053-1063. PubMed ID: 31556933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
    Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C
    Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
    Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avoidance of primary site adjuvant radiotherapy following transoral robotic surgery: a cohort study.
    Fradet L; Charters E; Gao K; Froggatt C; Palme C; Riffat F; Nguyen K; Wu R; Milross C; Clark JR
    ANZ J Surg; 2022 Mar; 92(3):511-517. PubMed ID: 35018703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.